MedTrace Logo

A Trial Examining the Treatment of Common Warts With Combination Liquid Nitrogen (LN2) and Cantharidin

NCT01084824 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2010-03-11

No results posted yet for this study

Summary

The purpose of the study was to see if liquid nitrogen, a commonly used treatment for warts, is more effective if it is used alone, or if it is more effective if combined with cantharidin, a topical treatment also commonly used for warts (verruca vulgaris).

Conditions

  • Verruca Vulgaris

Interventions

DRUG

Liquid nitrogen and cantharidin

Liquid nitrogen applied to wart(s), then cantharidin 1% topical applied afterward.

DRUG

Liquid nitrogen and topical placebo

Liquid nitrogen applied to wart(s), then placebo vehicle applied thereafter.

Sponsors & Collaborators

  • North Idaho Dermatology

    lead OTHER

Principal Investigators

  • Richard A Flygare, PhD · TUI University; North Idaho Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2008-06-30
Completion
2008-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01084824 on ClinicalTrials.gov